Article info

Download PDFPDF
Original research
Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease

Authors

  1. Correspondence to Dr Darryl Leong, Population Health Research Institute, McMaster University, Hamilton, ON L8L 2X2, Canada; leongd{at}phri.ca
View Full Text

Citation

Leong D, Aghel N, Hillis C, et al
Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease

Publication history

  • Received September 12, 2020
  • Revised December 3, 2020
  • Accepted December 7, 2020
  • First published January 8, 2021.
Online issue publication 
March 25, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.